01
Build the complete record
Reports, scans, sequencing, pathology, treatment history, response, timing, and physician notes are brought into one private workspace.
For complex cancer cases
We help you find treatment options and pursue treatment
When standard care is not enough, LightWay takes on the hard casework. We do maximal analysis of the tumor biology, generate potential treatment options, and help the patient and oncologist pursue those options through the routes the analysis supports.
We compare every relevant route: standard care, clinical trials, targeted and off-label drugs, personalized vaccines, international options, and special approval pathways.
Real people run the analysis and stay with the treatment coordination.
The public site contains no patient records. Private records stay private.
Our process
We stay with the case from records to pursuing treatment.
Patients and families should not have to become cancer researchers while also trying to make treatment decisions. LightWay builds the working record, performs maximal analysis of the tumor biology, develops and prioritizes treatment options, prepares the supporting evidence, helps pursue those options, and keeps the plan current as new results arrive.
02
Analyze the tumor biology
We do maximal analysis of the available tumor biology to find relevant targets, immune signals, tissue checks, and treatment implications.
03
Develop and rank the options
Standard care, trials, targeted and off-label drugs, vaccines, international options, and ways to pursue treatment are compared by evidence, timing, and feasibility.
04
Prepare and pursue the options
We work with the patient, family, oncologist, trial sites, manufacturers, and regulatory pathways to move the selected routes forward.
05
Keep the case current
New scans, blood tests, treatment response, trial changes, review dates, and open questions are tracked against the existing plan.
What we do
We look at every treatment option that may fit your cancer.
We begin with the current standard options, then extend the search across trials, targeted and off-label drugs, personalized vaccines, international care, and special approval routes. Every route stays tied to the patient's record and the evidence behind it.
Standard care
Put the current options in context
We connect approved treatments to the diagnosis, prior therapy, current disease state, and tumor biology.
Trials
Find trials that fit the case
We match biology, diagnosis, prior therapy, location, eligibility, and timing, then help prepare the outreach.
Targeted and off-label
Test drug ideas against the evidence
We connect tumor findings to possible drugs, check what supports or weakens the rationale, and identify any tissue confirmation needed.
Vaccine
Evaluate personalized vaccine paths
When the biology supports it, we examine peptide or mRNA vaccine routes, immune response, manufacturing, and timing.
International
Look beyond the patient's country
We review treatments and trials elsewhere when the evidence and practical requirements make them relevant.
Hard-to-reach options
Pursue hard-to-reach options
We help assemble the rationale, evidence, contacts, and physician-facing packet needed for a manufacturer or regulatory request.
How we help you pursue treatment
Finding a treatment option is only the first step.
LightWay does not stop after identifying an option. We help turn the option into a concrete treatment effort: the right questions, eligibility review, outreach, medical rationale, source evidence, and physician-facing material.
Care team
A decision-ready case packet
Current status, prioritized options, supporting evidence, unresolved questions, and the action each route requires.
Trial sites
Eligibility and outreach
Which studies are worth contacting, what records they need, and what might make the patient eligible or ineligible.
Drug companies
Manufacturer treatment requests
For drugs outside the usual route, we help assemble the medical rationale and supporting evidence.
Regulatory
Expanded or single-patient IND pathways
When appropriate, we help prepare the evidence a physician would need for a regulatory access discussion.
Routes to treatment
One analysis can lead to several ways to pursue treatment.
The first job is to understand the case. After that, the work branches: standard care, a trial, a personalized vaccine, a targeted or off-label drug, an international option, or a regulatory path may each require different work.
From record review to treatment routes
Open the full view
Start
The full cancer record
Reports, scans, pathology, sequencing, prior treatments, response, and open questions.
Review
Tumor biology and treatment context
What is happening now, what is targetable, what has already been tried, and what evidence is still needed.
Standard care
Compare the current options
Put approved treatments in context with the tumor biology, prior therapy, and current disease state.
Trial
Find a study that fits
Match diagnosis, markers, prior therapy, timing, and location.
Vaccine
Build a personalized route
Evaluate peptide or mRNA options when the tumor biology supports it.
Targeted or off-label
Build the drug rationale
Connect the tumor finding to the drug, evidence, tissue checks, and clinical context.
International
Review options outside the country
Identify relevant treatments or trials and what travel, timing, and records would be required.
Special approval
Prepare manufacturer or regulatory requests
Prepare the evidence a physician, manufacturer, or regulator may need for an expanded or single-patient pathway.
Output
A prioritized plan with treatment requests underway
The patient and oncologist can see what is possible now, what is being prepared, and what still needs to happen.
The exact route depends on the patient, the tumor, prior treatment, available tissue, location, timing, and physician review.
LightWay Hub
Everything about the case stays in one place.
As new results come in, LightWay keeps your current status, next steps, treatment options, preparation, and supporting evidence together for the patient and the care team.
Current status
What is true now and what needs attention
Disease state, recent changes, overdue follow-ups, and the next action.
Evidence
The reports and sources behind each finding
Pathology, surgery, imaging, labs, sequencing, notes, and literature remain traceable.
Tumor biology
Sequencing, mutations, expression, and immune markers
What makes this tumor specific, what may be targetable, and what needs confirmation.
Treatment choices
Standard care, trials, drugs, vaccines, and treatment routes
What can happen now, what is a backup, and what needs more evidence.
Preparation
What should be ready before it is needed
Biopsies, stains, trial packets, physician questions, and treatment request materials.
Tracking
What could change the plan later
Surveillance timing, milestones, trial changes, review dates, and open questions.
For the family around the patient
LightWay holds the case with you.
Families often become the record keeper, trial researcher, appointment planner, and second-opinion coordinator. LightWay brings everything together and gives the family a team to analyze the case, prepare the next steps, and stay involved as things change.
See where things stand
Current status, recent changes, overdue follow-ups, and the next action are kept in one view.
Understand what changed
New scans, labs, pathology, or sequencing are compared with the prior record and the existing plan.
Know what is being prepared
Treatment options, tissue checks, trial work, treatment request packets, and backup paths remain visible before they are needed.
Move treatment requests forward
We gather the rationale, source evidence, contacts, and physician-facing material, then help coordinate the route with the care team.
Important boundary: LightWay does not diagnose, prescribe, or replace medical care. We organize the record, analyze the evidence, develop potential options, and help patients and care teams pursue appropriate treatment pathways with the same information in view.